The National Institute of Pharmaceutical Education and Research (NIPER) is a group of public pharmaceutical research universities in India, established by the Government of India to develop indigenous expertise in pharmaceutical sciences, drug discovery, and biotechnology. The institutes are declared as Institutes of National Importance by an Act of Parliament and operate under the administrative control of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
Key facts
| Type | Public pharmaceutical research university |
|---|---|
| Status | Institute of National Importance |
| Founding statute | NIPER Act, 1998 |
| First institute | NIPER Mohali, Punjab |
| Parent ministry | Ministry of Chemicals and Fertilizers, Government of India |
| Department | Department of Pharmaceuticals |
| Country | India |
Overview
NIPER offers postgraduate and doctoral programmes in pharmaceutical sciences, including medicinal chemistry, pharmaceutics, pharmacology and toxicology, pharmaceutical analysis, biotechnology, natural products, pharmacy practice, and pharmaceutical management. The institutes function as centres for postgraduate teaching, advanced research, and consultancy in the pharmaceutical sector, and they collaborate with industry, regulatory agencies, and research bodies in India and abroad.
Background and establishment
The first institute, NIPER Mohali, was set up at Sahibzada Ajit Singh Nagar (S.A.S. Nagar), Punjab, and was conferred the status of an Institute of National Importance through the National Institute of Pharmaceutical Education and Research Act, 1998. The Act was subsequently amended to bring additional NIPERs within its ambit, expanding the network across several Indian states.
Network of institutes
In addition to the original campus at Mohali, NIPERs have been established in several states to address regional research needs and to support the Indian pharmaceutical industry. Campuses include:
- NIPER Mohali, Punjab
- NIPER Ahmedabad, Gujarat
- NIPER Hyderabad, Telangana
- NIPER Hajipur, Bihar
- NIPER Kolkata, West Bengal
- NIPER Guwahati, Assam
- NIPER Raebareli, Uttar Pradesh
Academics and admissions
NIPER offers Master of Science (M.S. Pharm.), Master of Pharmacy (M. Pharm.), Master of Technology (M. Tech. Pharm.), Master of Business Administration (MBA Pharm.), and Doctor of Philosophy (Ph.D.) programmes across pharmaceutical disciplines. Admission to master's programmes is conducted through the NIPER Joint Entrance Examination (NIPER JEE), a national-level test followed by counselling. The institutes also admit candidates supported by external fellowships such as those from CSIR, UGC, ICMR, and DBT for doctoral research.
Research and significance
NIPER campuses contribute to drug discovery and development, formulation research, analytical method development, regulatory toxicology, pharmacoeconomics, and traditional medicine. Faculty and students collaborate with the Indian pharmaceutical industry, which is among the largest producers of generic medicines globally, and with public laboratories under organisations such as the Council of Scientific and Industrial Research (CSIR) and the Indian Council of Medical Research (ICMR). The network is regarded as a key element of India's policy framework for self-reliance in medicines, vaccines, and bulk drugs.
Governance
The NIPERs are governed under the NIPER Act through a Board of Governors and a Senate at each institute, with overall coordination by the Department of Pharmaceuticals. Each campus is headed by a Director responsible for academic and administrative affairs.
Related topics
- Department of Pharmaceuticals
- Ministry of Chemicals and Fertilizers
- Pharmaceutical industry in India
- Institutes of National Importance
- Council of Scientific and Industrial Research
- Indian Council of Medical Research
- NIPER Mohali
- NIPER Hyderabad
References
- National Institute of Pharmaceutical Education and Research Act, 1998, Government of India.
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
- Wikidata entity Q28164180.